1.05
price up icon0.00%   0.00
after-market Handel nachbörslich: 1.05
loading

Enlivex Therapeutics Ltd Aktie (ENLV) Neueste Nachrichten

pulisher
01:29 AM

Will Enlivex Therapeutics Ltd. stock gain from strong economyTrade Entry Report & Weekly Setup with ROI Potential - newser.com

01:29 AM
pulisher
01:10 AM

Why Enlivex Therapeutics Ltd. stock is considered a top pickWatch List & Real-Time Buy Signal Alerts - newser.com

01:10 AM
pulisher
12:44 PM

Comparing Enlivex Therapeutics Ltd. in custom built stock radarsLayoff News & Smart Allocation Stock Reports - newser.com

12:44 PM
pulisher
12:31 PM

Backtesting results for Enlivex Therapeutics Ltd. trading strategiesGap Down & Weekly High Potential Alerts - newser.com

12:31 PM
pulisher
09:39 AM

Will Enlivex Therapeutics Ltd. stock maintain dividend yield2025 Short Interest & Low Drawdown Investment Strategies - newser.com

09:39 AM
pulisher
05:49 AM

Can Enlivex Therapeutics Ltd. stock maintain operating margins2025 Top Decliners & Safe Capital Growth Tips - newser.com

05:49 AM
pulisher
05:42 AM

Why analysts remain bullish on Enlivex Therapeutics Ltd. stockBull Run & Stock Timing and Entry Methods - newser.com

05:42 AM
pulisher
03:21 AM

Trend analysis for Enlivex Therapeutics Ltd. this weekTrade Exit Summary & Community Consensus Trade Signals - newser.com

03:21 AM
pulisher
Oct 31, 2025

Has Enlivex Therapeutics Ltd. found a price floorTrade Entry Summary & Community Verified Watchlist Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Technical signs of recovery in Enlivex Therapeutics Ltd.2025 Risk Factors & AI Enhanced Trade Execution Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can Enlivex Therapeutics Ltd. stock deliver consistent earnings growthQuarterly Performance Summary & Technical Pattern Based Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What’s the recovery path for long term holders of Enlivex Therapeutics Ltd.July 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Enlivex Therapeutics Ltd. stock deliver shareholder valueQuarterly Trade Report & High Accuracy Swing Trade Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How Enlivex Therapeutics Ltd. stock reacts to job market dataDividend Hike & Low Risk Investment Opportunities - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How to recover losses in Enlivex Therapeutics Ltd. stock2025 Retail Activity & Weekly High Momentum Picks - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 00:58:35 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-30 23:36:56 - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Using portfolio simulators with Enlivex Therapeutics Ltd. includedEarnings Recap Summary & AI Enhanced Execution Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Price action breakdown for Enlivex Therapeutics Ltd.Weekly Earnings Recap & Real-Time Stock Price Movement Reports - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Times Telegram

Oct 30, 2025
pulisher
Oct 29, 2025

D. Boral Capital Maintains Enlivex Therapeutics (ENLV) Buy Recommendation - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

ENLV Stock Rating Maintained at 'Buy' by D. Boral Capital | ENLV - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Shelby Star

Oct 29, 2025
pulisher
Oct 28, 2025

Risk Report: How Enlivex Therapeutics Ltd. stock responds to policy changesEarnings Recap Summary & Community Trade Idea Sharing Platform - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Enlivex Therapeutics to Present Phase IIa 3-month Data of Allocetra in Patients with Moderate-to-Severe Knee Osteoarthritis at the ACR Convergence 2025 - The Manila Times

Oct 28, 2025
pulisher
Oct 28, 2025

Enlivex Therapeutics Ltd. to Present Positive Phase IIa Clinical Data for Allocetra™ at ACR Convergence 2025 - Quiver Quantitative

Oct 28, 2025
pulisher
Oct 28, 2025

Enlivex (Nasdaq: ENLV) to present 3-month data; pain and function improvement in knee OA - Stock Titan

Oct 28, 2025
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Kapitalisierung:     |  Volumen (24h):